Ticey Harris, APRN
Acute Care · Las Vegas, NVNPI 1093115461
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,945 of the $4,086 with a category attached, or 72.1%. 23 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 32.0% of the total. Reporting peaked in 2022 at $1,899 and has fallen 87.5% since, to $237 in 2025. Among acute care clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 70 payments — averaging $58.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$1K
- Abiomed$662
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$281
- Boston Scientific$270
- Abbott$254
- Novartis$210
- plus $1K from 17 others
What the payments were for
- Travel & lodging$93623%
- Food & beverage$2,94572%
- Education$2045%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 9 | $1,306 |
| Abiomed | 6 | $662 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $281 |
| Boston Scientific | 11 | $270 |
| Abbott | 8 | $254 |
| Novartis | 10 | $210 |
| Biotronik Inc. | 3 | $204 |
| Medtronic | 2 | $177 |
| Novo Nordisk | 2 | $135 |
| Penumbra, Inc. | 1 | $122 |
| Pfizer | 1 | $85 |
| Kerecis Limited | 1 | $67 |
| Tactile Systems Technology Inc | 2 | $47 |
| Johnson & Johnson | 2 | $39 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $38 |
| Cvrx, Inc. | 1 | $34 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $31 |
| Chiesi USA, Inc. | 1 | $29 |
| AstraZeneca | 2 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Asahi Intecc USA, Inc. | 1 | $19 |
| Merck | 1 | $18 |
| Advanced Oxygen Therapy Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE CARDIOFORM Septal Occluder$1,042
- Impella$648
- LifeVest$281
- Micra$138
- Indigo System$122
- Varithena Administration Pack$114
How this compares
$4,086 in reported general payments places this provider in the 90th percentile of 129 acute care providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carvedilol | 23 | $314 |
| Hydralazine Hcl | 17 | $222 |
Paid to pharmacies, not to this prescriber.
Other acute care in Las Vegas
- Eileen JustoLas Vegas$20K
- Krystal CoffmanLas Vegas$6K
- Bibi KooLas Vegas$4K
- Helen BallertLas Vegas$3K
- Chalisa PansinLas Vegas$3K
- Jenesa Aguiluz-DizonLas Vegas$2K
- Brianna AbneyLas Vegas$2K
- Anita LaksonLas Vegas$2K
- Christine ApelLas Vegas$2K
- Carrie LoftonLas Vegas$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.